Quantification of recurrence risk based on number of adverse prognostic factors in women with stage I uterine endometrioid carcinoma
Open Access
- 1 December 2021
- journal article
- research article
- Published by Galenos Yayinevi in Journal of the Turkish-German Gynecological Association
- Vol. 22 (4), 262-267
- https://doi.org/10.4274/jtgga.galenos.2021.2021.0073
Abstract
Objective: The goal was to develop an updated model to predict the risk of recurrence, based on the number of adverse pathologic features in women with International Federation of Gynecology and Obstetrics stage I uterine endometrioid carcinoma, who did not undergo any adjuvant treatment. Material and Methods: Women at a single center who underwent surgical staging without adjuvant therapy between January 1990 and December 2019 were included. Cox proportional hazards model was used to identify independent predictors of relapse free survival (RFS). Prognostic groups were then created based on the number of independent predictors of recurrence that were identified (0, 1, or 2-3 risk factors). Overall survival (OS) and disease specific survival (DSS) were also calculated for each group. Results: In total 1133 women were eligible for inclusion. Median follow-up was 84 months. Independent prognostic factors of recurrence included: age >= 60; grade 2 or 3 differentiation; and presence of lymphovascular space invasion (LVSI). Due to the small number of patients with either 2 or 3 risk factors, these groups were combined into one (group 2/3). Isolated vaginal cuff recurrence was the most common site of recurrence in all study groups (2%, 7%, and 17% for groups 0, 1, and 2/3, respectively). Five-year RFS rates were 96%, 85%, and 57% for groups 0, 1, and 2/3 (p<0.01), respectively. Five-year DSS rates were 99%, 96%, and 85% and 5-year OS rates were 94%, 85%, and 62% (p<0.01), respectively. Conclusion: We identified older age, high grade, and presence of LVSI as independent predictors of recurrence for women with stage I uterine endometrioid carcinoma. Using these prognostic factors, recurrence risk can be quantified for individual patients, and these factors can be used in deciding the appropriate adjuvant management course.Keywords
This publication has 30 references indexed in Scilit:
- Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survivalGynecologic Oncology, 2014
- Lymphovascular Space Invasion (LVSI) Is an Isolated Poor Prognostic Factor for Recurrence and Survival Among Women With Intermediate- to High-Risk Early-Stage Endometrioid Endometrial CancerInternational Journal of Gynecologic Cancer, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma—A Prospective Randomized StudyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Fifteen-Year Radiotherapy Outcomes of the Randomized PORTEC-1 Trial for Endometrial CarcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Intravaginal Brachytherapy in FIGO Stage I Low-Risk Endometrial CancerInternational Journal of Gynecologic Cancer, 2009
- Lymphovascular Invasion Is a Significant Predictor for Distant Recurrence in Patients With Early-Stage Endometrial Endometrioid AdenocarcinomaAmerican Journal of Clinical Pathology, 2008
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyGynecologic Oncology, 2004
- Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trialThe Lancet, 2000
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991